Conditional BCL-2 Expression in Fibroblasts Promotes Persistent Pulmonary Fibrosis which is Reversible by Therapeutic BCL-2 Inhibition
Open Access
- 28 February 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease that develops in response to chronic epithelial injury. Unlike injury-induced homeostatic lung repair during which fibroblasts undergo apoptosis and clearance, the lungs of IPF patients continue to accumulate apoptosis-resistant, pro-fibrotic, extracellular matrix-producing fibroblasts. Here, we show that prevention of PDGFRα+ fibroblast apoptosis by conditional BCL-2 expression leads to the emergence and persistence of senescent, pro-fibrotic fibroblasts along with enduring, pathologic fibrotic lung remodeling. Additionally, spatial transcriptomic studies of human IPF lungs confirmed the presence of senescent, BCL-2 expressing α-smooth muscle actin+ myofibroblasts in fibrotic regions. Of translational significance, selective BCL-2 inhibition with ABT-199 in fibrotic mice re-engaged the apoptotic pathway in fibroblasts, reduced senescence, and promoted fibrosis resolution and lung regeneration. Our findings suggest that sustained BCL-2 expression in fibroblasts prevents homeostatic lung repair, drives persistent fibrosis and is a therapeutically relevant target to reverse persistent pulmonary fibrosis.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HL162607)
- National Heart, Lung, and Blood Institute (HL162607)
- National Heart, Lung, and Blood Institute (HL147860)
- National Heart, Lung, and Blood Institute (HL135156)
- National Heart, Lung, and Blood Institute (HL128439)
- National Heart, Lung, and Blood Institute (HL107202)
- National Heart, Lung, and Blood Institute (HL117004)
- National Heart, Lung, and Blood Institute (HL158668)
- National Heart, Lung, and Blood Institute (HL162607)
- National Heart, Lung, and Blood Institute (HL123442)
- National Heart, Lung, and Blood Institute (HL151865)
- National Heart, Lung, and Blood Institute (HL160770)
This publication has 92 references indexed in Scilit:
- The Aging Lung and Idiopathic Pulmonary FibrosisThe American Journal of the Medical Sciences, 2019
- Epithelial Injury and Dysfunction in the Pathogenesis of Idiopathic PulmonaryFibrosisThe American Journal of the Medical Sciences, 2019
- Isolation and Characterization of Mouse Fibroblasts2018
- Lung Pericytes and Resident FibroblastsThe American Journal of Pathology, 2016
- Decreased expression of autophagic beclin 1 protein in idiopathic pulmonary fibrosis fibroblastsJournal of Cellular Physiology, 2012
- BH3 Profiling Identifies Three Distinct Classes of Apoptotic Blocks to Predict Response to ABT-737 and Conventional Chemotherapeutic AgentsCancer Cell, 2007
- Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent AutophagyCell, 2005
- Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosisThe Journal of Pathology, 2003
- The myofibroblast in wound healing and fibrocontractive diseasesThe Journal of Pathology, 2003
- Apoptotic Activity is Increased in the Newly Formed Fibromyxoid Connective Tissue in Bronchiolitis Obliterans Organizing PneumoniaLung, 1999